Diamino Oxydase Enzyme
Histamine and histamine intolerance.
Histamine, histamine intoxication and intolerance.
Histamine intolerance and dietary management: A complete review.
Biomarkers for evaluation of mast cell and basophil activation.
Histamine N-Methyltransferase in the Brain.
Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence.
Diamine oxidase: an overview of historical, biochemical and functional aspects.
Diamine oxidase in relation to diamine and polyamine metabolism.
Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.
Polyamine Catabolism in Acute Kidney Injury.
It can be a complicated life being an enzyme.
Catabolism of polyamines.
Human Copper-Containing Amine Oxidases in Drug Design and Development.
Effects of histamine and diamine oxidase activities on pregnancy: a critical review.
Analysis of mast cell activation using diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry.
Wine and headache.
Putrescine metabolism and the study of diamine oxidase activity in vivo.
Semicarbazide-sensitive amine oxidase and kidney disease.
Monoamine oxidase and catecholamine metabolism.
Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation.
Human copper-dependent amine oxidases.
Inhibition and oxygen activation in copper amine oxidases.
Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO.
Metabolic strategies for the degradation of the neuromodulator agmatine in mammals.
Effects of amine oxidases in allergic and histamine-mediated conditions.
Polyamine metabolism and cancer.
Histamine: mercurial messenger in the gut.
Type-2 copper-containing enzymes.
S-adenosylmethionine decarboxylase as target of chemotherapy.
Gallium-labelled peptides for imaging of inflammation.
Amine oxidases and tumors.
Biological effects of aminoguanidine: an update.
Sulfur metabolism in AIDS: cystamine as an anti-HIV agent.
Tyrosine-derived quinone cofactors.
The role of amine oxidases in xenobiotic metabolism.
Histamine Clearance Through Polyspecific Transporters in the Brain.
Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Copper, lysyl oxidase, and extracellular matrix protein cross-linking.
Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review.
Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation.
VAP-1: an adhesin and an enzyme.
Semicarbazide-sensitive amine oxidase: current status and perspectives.
Lysyl oxidases: a novel multifunctional amine oxidase family.
Metabolism and function of gastric histamine in health and disease.
Vascular adhesion protein-1: Role in human pathology and application as a biomarker.
Polyamine catabolism and disease.
Structure-activity relationships of SSAO/VAP-1 arylalkylamine-based substrates.
Ultrastructural localization of histamine in human basophils and mast cells; changes associated with anaphylactic degranulation and recovery demonstrated with a diamine oxidase-gold probe.
Methods for the enhancement of fingermarks in blood.
Semicarbazide-sensitive amine oxidases: some biochemical properties and general considerations.
Aerobic catalytic systems inspired by copper amine oxidases: recent developments and synthetic applications.
Histamine: entering physiology.
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey.
Polyamines. An introduction.
Histaminase and related amine oxidases.
Protein-Derived Cofactors Revisited: Empowering Amino Acid Residues with New Functions.
Amine oxidases in apoptosis and cancer.
Cellular and molecular basis of intestinal and pancreatic adaptation.
Adhesion molecules in CNS disorders: biomarker and therapeutic targets.
Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do.
Histamine: new thoughts about a familiar mediator.
Hepatic consequences of vascular adhesion protein-1 expression.
Potential anticancer application of polyamine oxidation products formed by amine oxidase: a new therapeutic approach.
Antiviral activity of oxidized polyamines.
Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention.
Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications.
Nanoparticle strategies for cancer therapeutics: Nucleic acids, polyamines, bovine serum amine oxidase and iron oxide nanoparticles (Review).
Cardiac anaphylaxis: pathophysiology and therapeutic perspectives.
Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target.
Modelling the roles of MAO and SSAO in glucose transport.
Cell surface monoamine oxidases: enzymes in search of a function.
Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Plant histaminase as an investigational drug in splanchnic artery occlusion and reperfusion.
New perspectives on the role of amine oxidases in physiopathology.
Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator.
Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology.
Anticancer drugs and hyperthermia enhance cytotoxicity induced by polyamine enzymatic oxidation products.
VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation.
The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease.
Trihydroxyphenylalanine quinone (TPQ) from copper amine oxidases and lysyl tyrosylquinone (LTQ) from lysyl oxidase.
Food, food additives and urticaria.
Histamine content and secretion in basophils and mast cells.
Oxidation of polyamines and brain injury.
Semicarbazide-sensitive amine oxidase: role in the vasculature and vasodilation after in situ inhibition.
The immune system as a physiological indicator of marginal copper status?
Amine oxidases of the quinoproteins family: their implication in the metabolic oxidation of xenobiotics.
Studies on semicarbazide-sensitive amine oxidase in patients with diabetes mellitus and in transgenic mice.
The role of polyamine catabolism in anti-tumour drug response.
Targeting vascular adhesion protein-1 to treat autoimmune and inflammatory diseases.
Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects.
Tracing nanoparticles and photosensitizing molecules at transmission electron microscopy by diaminobenzidine photo-oxidation.
Factors affecting the relative importance of amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans.
Ethanol and polyamine metabolism in adult and fetal tissues: possible implication in fetus damage.
Newly discovered redox cofactors: possible nutritional, medical, and pharmacological relevance to higher animals.
Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.
Pharmacology of the placenta.
Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected?
Inhibition of diamine oxidases and polyamine oxidases by diamine-based compounds.
Substrate-specificity of mammalian tissue-bound semicarbazide-sensitive amine oxidase.
Semicarbazide-sensitive amine oxidase (SSAO) in the brain.
Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain).
Aspects of the biochemical pharmacology of methyl glyoxal bis(guanylhydrazone).
Mammalian Cu-containing amine oxidases (CAOs): new methods of analysis, structural relationships, and possible functions.
Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo.
Pea seedling histaminase as a novel therapeutic approach to anaphylactic and inflammatory disorders. A plant histaminase in allergic asthma and ischemic shock.
The biological functions of polyamine oxidation products by amine oxidases: perspectives of clinical applications.
Further developments in research on the chemistry and pharmacology of synthetic quinuclidine derivatives.
Semicarbazide-sensitive amine oxidase and mortality in chronic heart failure.
Bacterial production and destruction of histamine in foods, and food poisoning caused by histamine.
The paraneoplastic syndromes associated with carcinoma of the thyroid gland.
In search of a new therapeutic target for the treatment of genetically triggered thoracic aortic aneurysms and cardiovascular conditions: insights from human and animal lathyrism.
Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes.
Biogenesis of novel quinone coenzymes.
Polyamines in mammalian tumors. Part II.
Enzymes and isoenzymes in urine.
The C cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A review.
Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus.
Copper amine oxidases: structure and function.
On the primary structure of membrane-bound semicarbazide-sensitive amine oxidase (SSAO).
Methods for characterizing TPQ-containing proteins.
Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications.
Lymphocyte trafficking mediated by vascular adhesion protein-1: implications for immune targeting and cardiovascular disease.
Studies in familial (medullary) thyroid carcinoma.
Enzyme assays in the management of pregnancy.
Enzymatic control of leukocyte trafficking: role of VAP-1.
Clinical chemistry of polyamines.
Properties of mammalian tissue-bound semicarbazide-sensitive amine oxidase: possible clues to its physiological function?
Semicarbazide-sensitive amine oxidase activity exerts insulin-like effects on glucose metabolism and insulin-signaling pathways in adipose cells.
Determination of amine oxidases.
Vascular adhesion protein-1 (VAP-1)--a new adhesion molecule recruiting lymphocytes to sites of inflammation.
Tumor markers in the recognition and management of poorly differentiated neoplasms and cancers of unknown primary.
Properties and functions of tissue-bound semicarbazide-sensitive amine oxidases in isolated cell preparations and cell cultures.
Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications.
Some aspects of the pharmacology of semicarbazide-sensitive amine oxidases.
Some properties of semicarbazide-sensitive amine oxidases.
Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor.
A novel endothelial cell molecule mediating lymphocyte binding in humans.
Medullary carcinoma of the thyroid gland: use of biochemical parameters in detection and surgical management of the tumor.
Neuroendocrine-related biochemistry in the spectrum of human lung cancers.
Poorly differentiated lung cancer.
Polyamines in intestinal adaptation and disease.
Tumor markers in endocrine malignancies.
Enzymatic indices of fetal environment.
Nonadrenergic imidazoline binding sites and amine oxidase activities in fat cells.
Histamine and the parietal cell.
Semicarbazide-sensitive amine oxidases: widespread occurrence and many names and faces.
Ectopic (inappropriate) hormone production by tumors: mechanisms involved and the biological and clinical implications.
Histaminergic mechanisms in the vertebrate visual system.
Placental function tests: a review of tests showing promise but not yet established.
Molecular and cellular properties of eosinophils. (A review).
Laboratory assessment of diabetic pregnancy. A brief review.
Polyamine recycling enzymes in human cancer cells.
Monoamine oxidases: versatility of catalytic properties and possible biological functions.